Smithers Rapra Publish an 'Update on Chitosan'

New Book: 'Update on Chitosan: A Non-Viral Gene Delivery Vector' from Smithers Rapra.

Among the various natural polymer-based gene delivery vectors, chitosan is the most prominent. As a biocompatible, biodegradable, nontoxic and easily modifiable material, chitosan has been widely researched for a variety of biomedical applications such as wound healing, drug/gene delivery systems, implant coatings and tissue engineering/regeneration.

The objective of this book is to integrate the concepts related to chitosan and its derivative-based drug/gene delivery carriers. For example, the success of the gene delivery system mainly depends upon the uptake by the cells, unpacking behaviour of pDNA/siRNA from the vector and its intracellular trafficking. Such concepts are introduced and discussed, in addition to the various applications of chitosan as a drug delivery system in wound healing, tissue engineering and in gene delivery.

This book is an excellent resource for the academic faculty, graduate students and professionals interested in chitosan-based drug/gene technologies.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Smithers Rapra Technology Ltd. (2019, February 09). Smithers Rapra Publish an 'Update on Chitosan'. AZoM. Retrieved on October 31, 2020 from https://www.azom.com/news.aspx?newsID=33371.

  • MLA

    Smithers Rapra Technology Ltd. "Smithers Rapra Publish an 'Update on Chitosan'". AZoM. 31 October 2020. <https://www.azom.com/news.aspx?newsID=33371>.

  • Chicago

    Smithers Rapra Technology Ltd. "Smithers Rapra Publish an 'Update on Chitosan'". AZoM. https://www.azom.com/news.aspx?newsID=33371. (accessed October 31, 2020).

  • Harvard

    Smithers Rapra Technology Ltd. 2019. Smithers Rapra Publish an 'Update on Chitosan'. AZoM, viewed 31 October 2020, https://www.azom.com/news.aspx?newsID=33371.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit